The largest database of trusted experimental protocols

Valsartan

Manufactured by LKT Laboratories
Sourced in United States

Valsartan is a pharmaceutical ingredient used in the production of various medications. It functions as an angiotensin II receptor antagonist, which helps to regulate blood pressure by blocking the effects of a hormone called angiotensin II. This product is intended for use in regulated pharmaceutical manufacturing processes.

Automatically generated - may contain errors

3 protocols using valsartan

1

Angiotensin II Receptor Antagonists Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Telmisartan, candesartan, losartan and valsartan were obtained from LKT Laboratories (St. Paul, MN, USA), and prepared as 10 mg/mL stock solutions in dimethyl sulfoxide (DMSO). GW9662 and troglitazone were obtained from Cayman Chemical (Ann Arbor, MI, USA). GW9662 was prepared as a 5 mg/mL stock solution in dimethyl formamide. troglitazone was prepared as a 10 mg/mL stock solution in DMSO. The stock solutions were stored as aliquots at −20°C.
+ Open protocol
+ Expand
2

Preparation of Stock Solutions for Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Acetaminophen, tert-butylhydroquinone, and tienilic acid were purchased from Sigma-Aldrich (St. Louis, MO, USA). Aminopyrine, sulfamethoxazole, and forskolin were purchased from Fujifilm Wako Pure Chemical Co. (Osaka, Japan). Erythromycin, valsartan, and warfarin were purchased from LKT Laboratories, Inc. (St Paul, MN, USA). Nevirapine, pravastatin, and procainamide were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Stock solutions of all test drugs were prepared in dimethyl sulfoxide (DMSO) at a concentration of 200 mM. Each solution was adequately diluted with Dulbecco's modified Eagle's medium (DMEM) (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) so that the final concentration of DMSO in the culture medium was 0.5%.
+ Open protocol
+ Expand
3

Antitumor Efficacy of Angiotensin II Receptor Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six to eight‐week‐old C57B/6 and Balb/c mice were inoculated s.c. in the flank with 4 × 105 MC38 and with 4 × 105 CT26 cells on day 0, respectively. Mice were injected i.p. with vehicle (PBS), valsartan (15 mg/kg; LKT Laboratories, St Paul, MN, USA), or candesartan (6 mg/kg; Funakoshi, Tokyo, Japan) every day from day 6. In the combined therapy, anti‐PD‐L1 or isotype antibody (Ab) (200 μg/body; Bio X Cell, Lebanon, NH, USA) was given on day 7, 10, and 13. For cell depletion, Anti‐CD8 or isotype Ab (200 μg/body; Bio X Cell) was given i.p. on day 1, 4, 5, 6, 12, and 19. Tumor size was measured using the following formula: volume = 0.5 × (width)2 × (length). Tumor antigen (gp70)‐specific T‐cell responses were detected by modification of our previously reported method.19 See Appendix S1 for more information.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!